Journal of Psychosocial Nursing and Mental Health Services | Two Drugs Approved for Major Depressive DisorderSummertime was a hot season for new therapies in the treatment of major depressive disorder (MDD), with U.S. Food and Drug Administration (FDA) approval of two new pharmaceutical agents....
Journal of Psychosocial Nursing and Mental Health Services | Two Drugs Approved for Major Depressive DisorderSummertime was a hot season for new therapies in the treatment of major depressive disorder (MDD), with U.S. Food and Drug Administration (FDA) approval of two new pharmaceutical agents.Fet...
Major depressive disorder (MDD), commonly referred to as depression, is a mental disorder characterized by moo... FN Release - 《Chicago Weekend》 被引量: 8发表: 2013年 FDA-Approved Drugs to Treat Depression Journal of Psychosocial Nursing and Mental Health Services | The Clip & Save: Drug ...
Rexultiis a brand name ofbrexpiprazole, approved by the FDA in the following formulation(s): REXULTI (brexpiprazole - tablet;oral) Manufacturer:OTSUKA Approval date: July 10, 2015 Strength(s): 0.25MG[RLD], 0.5MG[RLD], 1MG[RLD], 2MG[RLD], 3MG[RLD], 4MG[RLD] ...
Previously approved medications that have gained new FDA approval for the treatment of additional medical conditions.
Duloxetine (Cymbalta®) is an orally administered, selective serotonin and noradrenaline reuptake inhibitor (SNRI) that has been approved for the treatment of major depressive disorder (MDD). Based on a considerable body of evidence, duloxetine at dosages ranging from 40 to 120 mg/day was effect...
INTRODUCTION: Major depressive disorder (MDD) remains a major public health concern, and one that continues to suffer an incompletely-met need for effective and acceptable treatments. The development of antidepressants, to date, has focused primarily on increasing monoamine neurotransmission with increasing...
Caplyta may soon become the first treatment approved for MDD and depressive symptoms associated with bipolar I and II in more than 15 years, the company said. “We believe Caplyta has the potential to become a new standard of care for the treatment of some of today...
While some biotechnology companies search for new drug candidates, Protarga, Inc. (King of Prussia, PA) is searching for better ways to get FDA-approved dr... C Potera - 《Genetic Engineering News》 被引量: 6发表: 2001年 David Herzberg, Happy Pills in America: From Miltown to Prozac,Th...
Levomilnacipran ER is an enantiomer of milnacipran, approved recently by FDA for the treatment of major depressive disorder (MDD). This review helps the clinician to choose better drugs according to patient's clinical needs. Significant efforts must be taken for conducting clinical trials assessing ...